• Lyso-Tracker Red DND-99: Quantitative Lysosome Analysis in C

  2026-04-21

  Explore how Lyso-Tracker Red DND-99 empowers high-precision lysosome labeling in live cells, enabling advanced quantitative analysis of lysosomal dynamics in cancer biology. This article uncovers practical assay insights and novel applications not covered elsewhere.

• WY-14643 (Pirinixic Acid): PPARα Agonism in Translational Me

  2026-04-20

  This thought-leadership article explores the translational value of WY-14643 (Pirinixic Acid), a potent and selective PPARα agonist, in metabolic disorder research. Integrating mechanistic findings, recent in vivo validation, and workflow strategy, it offers a strategic guide for researchers seeking to advance metabolic, inflammatory, and regenerative studies. Featuring direct evidence from YAP-TEAD–mediated PPARα activation in murine liver regeneration and highlighting APExBIO’s product reliability, the piece contextualizes WY-14643 in the evolving competitive landscape and charts a forward-looking outlook grounded in peer-reviewed evidence.

• miR-184 Regulates Granulosa Cell Survival via SMAD3 in Ovari

  2026-04-20

  This study identifies miR-184 as a critical ovary-enriched microRNA that is transcriptionally activated by SREBF2 and downregulated during follicular atresia. The authors demonstrate that miR-184 induces SMAD3 expression through both saRNA activity and mRNA stabilization, suppressing granulosa cell apoptosis and highlighting a conserved anti-atretic mechanism relevant for ovarian health.

• ddATP in DNA Damage Response: Beyond Sequencing Applications

  2026-04-19

  Uncover the advanced role of ddATP (2',3'-dideoxyadenosine triphosphate) in DNA damage response and break-induced replication studies. This in-depth analysis explores mechanisms and practical insights not found in standard Sanger sequencing guides.

• Tubastatin A Mitigates Cardiac Injury via Pyroptosis/Necropt

  2026-04-18

  This study demonstrates that Tubastatin A, a selective HDAC6 inhibitor, significantly reduces myocardial damage following cardiac arrest and resuscitation in a porcine model. The protective effects are linked to the inhibition of GSDME-mediated pyroptosis and MLKL-mediated necroptosis, providing mechanistic insight for translational research on post-resuscitation cardiac injury.

• Thiothixene: Typical Antipsychotic Agent for Efferocytosis A

  2026-04-17

  Thiothixene stands out as both a typical antipsychotic agent and a powerful enhancer of macrophage efferocytosis in vitro. This article delivers advanced, protocol-driven guidance for leveraging its dual utility in neuropsychiatric and immunological research, highlighting troubleshooting strategies and translational value.

• α7nAChR-Driven Endothelial Pyroptosis in HIV-1 gp120 BBB Inj

  2026-04-16

  This study reveals that HIV-1 gp120 triggers pyroptosis in brain microvascular endothelial cells via the α7 nicotinic acetylcholine receptor, leading to blood–brain barrier disruption. By elucidating the ROS/NF-κB/NLRP3 inflammasome pathway and demonstrating that memantine/metformin inhibit this process, the work highlights a new therapeutic target for HIV-associated neurocognitive disorder.

• AR Heterogeneity Drives Divergent Prostate Cancer Therapy Re

  2026-04-15

  This study dissects how androgen receptor (AR) heterogeneity in prostate cancer underpins distinct biological behaviors and resistance to castration and enzalutamide therapy. By linking AR expression patterns to therapeutic outcomes and identifying BCL-2 as a targetable vulnerability, the work informs precision strategies for castration-resistant prostate cancer.

• BCL-XL Inhibitor A-1155463: Selectivity and Preclinical Impa

  2026-04-14

  BCL-XL inhibitor A-1155463 is a highly selective small molecule that potently antagonizes BCL-XL, offering advanced tools for apoptosis induction in BCL-XL-dependent cells. Its nanomolar affinity and proven tumor growth inhibition underscore its value for hematological malignancies research.

• Lanabecestat (AZD3293): Optimizing BACE1 Inhibition Workflow

  2026-04-13

  Lanabecestat (AZD3293) empowers Alzheimer’s disease research with potent, blood-brain barrier-penetrant BACE1 inhibition, enabling precise modulation of amyloid-beta production while preserving neuronal function. This guide demystifies experimental setup, protocol enhancements, and troubleshooting strategies to maximize reproducibility and translational relevance in amyloidogenic pathway studies.

• Temozolomide: Precision DNA Damage Tool for Glioma Research

  2026-04-13

  Temozolomide from APExBIO empowers researchers to model DNA repair and chemotherapy resistance with unmatched precision in glioma and advanced cancer systems. This guide details actionable protocols, innovative workflows, and expert troubleshooting strategies to unlock deeper insights into ATRX-deficient cancer biology.

• Norovirus Hijacks NINJ1 for Selective Viral Protein Secretio

  2026-04-12

  Song et al. uncover a novel mechanism by which murine norovirus (MNoV) exploits host NINJ1 to selectively secrete its NS1 protein, revealing new facets of regulated plasma membrane rupture and viral immune evasion. These findings provide critical insights into unconventional secretion pathways and the interplay between viral pathogenesis and host cell death machinery.

• Hypoxia-Induced Cognitive Impairment: Choroid Plexus and AMP

  2026-04-12

  This study reveals that severe hypoxic exposure impairs cognitive function in mice via choroid plexus barrier disruption, driven by AMPK pathway dysregulation and M1 macrophage polarization. The findings highlight the choroid plexus as a central node linking metabolic stress to CNS homeostasis and suggest new experimental targets for hypoxia-induced cognitive disorders.

• Doxorubicin in Cancer Research: Protocols, Applications, and

  2026-04-11

  Doxorubicin (Adriamycin) is a gold-standard chemotherapeutic agent for solid tumors and hematologic malignancies, enabling high-content phenotypic screens and apoptosis induction in cancer cells. This article deconstructs optimized workflows, advanced assay designs, and troubleshooting strategies for leveraging Doxorubicin, grounded in recent deep learning-enabled toxicity screening advances.

• Amiloride (MK-870): Precision Tools for Ion Channel Research

  2026-04-11

  Amiloride (MK-870) offers unparalleled specificity as both an ENaC and uPAR inhibitor, making it indispensable for dissecting sodium channel function and cellular uptake pathways. This guide delivers actionable protocols and troubleshooting strategies to maximize reproducibility and data quality in sodium channel and endocytosis research.

15952 records 1/1064 page Next 12345 下5页 Last page